Zhu, Eric F <br/><br/>
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.  [electronic resource] 

 -  Cancer cell  Apr 2015 
 - 489-501 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccell.2015.03.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptive Immunity<br/>Animals<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Drug Synergism<br/>Half-Life<br/>Immunity, Innate<br/>Immunotherapy<br/>Interleukin-2--metabolism<br/>Killer Cells, Natural--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasms--immunology